Prevail 24/7 AM and PM
Natural health product licensed in Canada
- Licence holder
- Valentus, Inc.
- NPN or DIN-HM
- 80104343
- Status
- Active licence
- Licence date
- 15 September 2020
- Revision date
- Not provided
- Form
- Kit
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Turnera diffusa Willd. ex Schult.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Prunus cerasus Source : Fruit | 100 mg | Not calculated |
| Alpinia galanga Source : Rhizome Extraction ratio : 10:1 Dry plant equivalent : 100 mg | 10 mg | Not calculated |
| Rubus idaeus Source : Fruit Extract : Matériel brut frais Extraction ratio : 100:1 Dry plant equivalent : 5,000 mg | 50 mg | Not calculated |
| L-théanine Source : L-Théanine | 25 mg | Not calculated |
| Rubus idaeus Source : Fruit Extraction ratio : 100:1 Dry plant equivalent : 5,000 mg | 50 mg | Not calculated |
| Morus alba Source : Feuille Extraction ratio : 40:1 Dry plant equivalent : 400 mg | 12.5 mg | Not calculated |
| Turnera diffusa Source : Feuille Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 200 mg | 50 mg | Not calculated |
Non-medicinal ingredients
farine de riz, Stéarate de magnésium, Hypromellose, Silice
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | Not specified | Not specified |
Uses authorised in Canada
-
Source of antioxidants. Helps temporarily to promote alertness and wakefulness, and to enhance cognitive performance. Helps temporarily to relieve fatigue, to promote endurance, and to enhance motor performance. Helps temporarily to enhance (physical) energy.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Stop use if hypersensitivity or allergy occurs or if you experience headache, confusion, or nausea. Stop use and seek medical attention immediately if you experience dizziness, confusion, muscle weakness or pain, abnormal heart beat and/or difficulty breathing.
- Contre-indications
Do not use this product if you are pregnant or breastfeeding. If you have heart disease, high or low blood pressure, liver or kidney disorder, diabetes or edema (swelling of hands, face and feet) or are taking products containing diuretics, do not use. Do not drive or use machinery for 5 hours after taking melatonin. If you experience sweating, paleness, chills, headache, dizziness, and/or confusion, discontinue use and consult a healthcare practitioner (as these may be symptoms of serious low blood sugar).
Source
Official Health Canada record, licence 80104343
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.